Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives-Reference-Cited by-同舟云学术

Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives

Published:2016-05 Issue:5 Volume:69 Page:775-787
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Bayne Christopher E.,Williams Stephen B.,Cooperberg Matthew R.,Gleave Martin E.,Graefen Markus,Montorsi Francesco,Novara Giacomo,Smaldone Marc C.,Sooriakumaran Prasanna,Wiklund Peter N.,Chapin Brian F.

Publisher

Elsevier BV

Subject

Urology

Reference77 articles.

1. Twenty years of PSA: from prostate antigen to tumor marker;De Angelis;Rev Urol,2007

2. No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period;Wu;Cancer,2014

3. Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346);Tangen;J Urol,2012

4. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer;Heidenreich;Eur Urol,2014

5. National Comprehensive Cancer Network. Prostate cancer (Version 2.2014). http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current evidence on local therapy in oligometastatic prostate cancer;Current Opinion in Urology;2024-02-02

2. Hypofractionated versus conventional fractionation external beam radiotherapy in intermediate and high risk localized prostate cancer;Discover Oncology;2024-02-02

3. Palliative radiotherapy in oligometastases;Palliative Radiation Oncology;2024

4. Is there a role for radical prostatectomy in the management of oligometastatic prostate cancer? A systematic review;Prostate Cancer and Prostatic Diseases;2023-11-20

5. Hypofractionated Versus Conventional Fractionation External Beam Radiotherapy in Intermediate and High Risk Localized Prostate Cancer;2023-10-17